• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种编码整合膜蛋白的新基因在肾病性胱氨酸病中发生突变。

A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.

作者信息

Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore S A, Callen D F, Gribouval O, Broyer M, Bates G P, van't Hoff W, Antignac C

机构信息

Division of Medical and Molecular Genetics, United Medical and Dental Schools, Guy's Hospital, London, UK.

出版信息

Nat Genet. 1998 Apr;18(4):319-24. doi: 10.1038/ng0498-319.

DOI:10.1038/ng0498-319
PMID:9537412
Abstract

Nephropathic cystinosis, an autosomal recessive disorder resulting from defective lysosomal transport of cystine, is the most common inherited cause of renal Fanconi syndrome. The cystinosis gene has been mapped to chromosome 17p13. We found that the locus D17S829 was homozygously deleted in 23 out of 70 patients, and identified a novel gene, CTNS, which mapped to the deletion interval. CTNS encodes an integral membrane protein, cystinosin, with features of a lysosomal membrane protein. Eleven different mutations, all predicted to cause loss of function of the protein, were found to segregate with the disorder.

摘要

肾性胱氨酸病是一种常染色体隐性疾病,由溶酶体对胱氨酸的转运缺陷引起,是肾性范科尼综合征最常见的遗传病因。胱氨酸病基因已被定位到17号染色体p13区域。我们发现,在70例患者中,有23例的D17S829位点纯合缺失,并鉴定出一个新基因CTNS,该基因定位于缺失区间。CTNS编码一种整合膜蛋白胱氨酸转运体,具有溶酶体膜蛋白的特征。我们发现11种不同的突变,均预计会导致该蛋白功能丧失,且这些突变与该疾病相关。

相似文献

1
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.一种编码整合膜蛋白的新基因在肾病性胱氨酸病中发生突变。
Nat Genet. 1998 Apr;18(4):319-24. doi: 10.1038/ng0498-319.
2
Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation.胱氨酸病的分子分析:法裔加拿大人中最常见突变可能起源于爱尔兰。
Eur J Hum Genet. 1999 Sep;7(6):671-8. doi: 10.1038/sj.ejhg.5200349.
3
Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis.对德国和瑞士裔肾病型胱氨酸病患者的CTNS基因分析。
Hum Mutat. 2002 Sep;20(3):237. doi: 10.1002/humu.9063.
4
CTNS mutations in patients with cystinosis.胱氨酸病患者的CTNS基因突变
Hum Mutat. 1999;14(6):454-8. doi: 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H.
5
[From gene to disease: cystinosis].从基因到疾病:胱氨酸贮积症
Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8.
6
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.胱氨酸病的分子发病机制:CTNS 突变对胱氨酸转运体的转运活性及亚细胞定位的影响
Hum Mol Genet. 2004 Jul 1;13(13):1361-71. doi: 10.1093/hmg/ddh152. Epub 2004 May 5.
7
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.包含肾病性胱氨酸病基因(CTNS)的基因组区域:200kb片段的完整测序以及在常见的导致胱氨酸病的缺失区域内发现一个新基因。
Genome Res. 2000 Feb;10(2):165-73. doi: 10.1101/gr.10.2.165.
8
Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis.14种新的CTNS突变的鉴定及与胱氨酸病相关的7种剪接位点突变的特征分析。
Hum Mutat. 2002 Dec;20(6):439-46. doi: 10.1002/humu.10141.
9
Mutations of CTNS causing intermediate cystinosis.导致中间型胱氨酸病的CTNS基因突变。
Mol Genet Metab. 1999 Aug;67(4):283-93. doi: 10.1006/mgme.1999.2876.
10
Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin.胱氨酸病的表型严重程度因CTNS基因突变而异:对胱氨酸转运蛋白模型的预测影响。
Hum Mol Genet. 1999 Dec;8(13):2507-14. doi: 10.1093/hmg/8.13.2507.

引用本文的文献

1
JIP4 deficiency causes a lysosomal storage disease arising from impaired cystine efflux.JIP4缺乏会导致一种由胱氨酸外排受损引起的溶酶体贮积病。
bioRxiv. 2025 Jun 8:2025.06.06.657909. doi: 10.1101/2025.06.06.657909.
2
Pediatric cystinosis: Corneal cystine deposits and papilledema in a 4-year-old:  A case report.小儿胱氨酸病:一名4岁患儿的角膜胱氨酸沉积和视乳头水肿:病例报告
Med Int (Lond). 2025 May 14;5(4):43. doi: 10.3892/mi.2025.242. eCollection 2025 Jul-Aug.
3
Computational prediction of deleterious nonsynonymous SNPs in the CTNS gene: implications for cystinosis.
CTNS基因中有害非同义单核苷酸多态性的计算预测:对胱氨酸病的意义。
BMC Genom Data. 2025 May 15;26(1):35. doi: 10.1186/s12863-025-01325-2.
4
Long-term outcomes in nephropathic cystinosis: a review.肾性胱氨酸病的长期预后:综述
Pediatr Nephrol. 2025 May 14. doi: 10.1007/s00467-025-06790-6.
5
Exploring the potential of bacterial-derived EVs for targeted enzyme replacement therapy: mechanisms, applications, and future directions.探索细菌衍生细胞外囊泡用于靶向酶替代疗法的潜力:作用机制、应用及未来方向。
Arch Microbiol. 2025 Apr 10;207(5):118. doi: 10.1007/s00203-025-04294-3.
6
Novel mechanism for tubular injury in nephropathic cystinosis.肾病性胱氨酸病肾小管损伤的新机制。
Elife. 2025 Mar 20;13:RP94169. doi: 10.7554/eLife.94169.
7
Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles.用于眼胱氨酸病的基于金纳米颗粒的诊疗隐形眼镜。
Biosensors (Basel). 2025 Jan 3;15(1):16. doi: 10.3390/bios15010016.
8
Syndromic Retinitis Pigmentosa: A Narrative Review.综合征性视网膜色素变性:一篇综述
Vision (Basel). 2025 Jan 20;9(1):7. doi: 10.3390/vision9010007.
9
An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients.一项评估0.55%半胱胺滴眼液在日本胱氨酸病患者中的疗效和安全性的开放标签III期研究。
Clin Ophthalmol. 2024 Nov 25;18:3457-3471. doi: 10.2147/OPTH.S479770. eCollection 2024.
10
Reconstitution of Rab11-FIP4 Expression Rescues Cellular Homeostasis in Cystinosis.胱氨酸病中 Rab11-FIP4 表达的重建挽救了细胞内稳态。
Mol Cell Biol. 2024;44(12):577-589. doi: 10.1080/10985549.2024.2410814. Epub 2024 Oct 22.